Centaurus Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Sell |
3,737
-237
| -6% | -$7.99K | 0.01% | 875 |
|
|
2025
Q1 | $126K | Buy |
3,974
+25
| +0.6% | +$793 | 0.01% | 819 |
|
|
2024
Q4 | $153K | Buy |
3,949
+200
| +5% | +$7.75K | 0.01% | 747 |
|
|
2024
Q3 | $169K | Buy |
3,749
+246
| +7% | +$11.1K | 0.01% | 680 |
|
|
2024
Q2 | $146K | Buy |
+3,503
| New | +$146K | 0.01% | 684 |
|
|
2024
Q1 | – | Sell |
-3,185
| Closed | -$147K | – | 800 |
|
|
2023
Q4 | $147K | Buy |
3,185
+406
| +15% | +$18.7K | 0.01% | 660 |
|
|
2023
Q3 | $113K | Buy |
2,779
+118
| +4% | +$4.8K | 0.01% | 695 |
|
|
2023
Q2 | $129K | Buy |
2,661
+22
| +0.8% | +$1.07K | 0.01% | 675 |
|
|
2023
Q1 | $130K | Buy |
2,639
+489
| +23% | +$24.1K | 0.01% | 776 |
|
|
2022
Q4 | $109K | Buy |
+2,150
| New | +$109K | 0.01% | 766 |
|
|
2022
Q2 | – | Sell |
-1,749
| Closed | -$105K | – | 860 |
|
|
2022
Q1 | $105K | Buy |
1,749
+31
| +2% | +$1.86K | 0.01% | 852 |
|
|
2021
Q4 | $136K | Buy |
1,718
+436
| +34% | +$34.5K | 0.01% | 794 |
|
|
2021
Q3 | $114K | Buy |
+1,282
| New | +$114K | 0.01% | 825 |
|